(Q44585463)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

The relationship between soluble receptor of interleukin-6 with angiogenic cytokines and proliferation markers in multiple myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Michael G. Alexandrakis

8

object named as

Michael G Alexandrakis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1

George Tsirakis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

2

Constantina A Pappa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

4

Anna Boula

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Maria Kaparou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Vaitsa Katsomitrou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Stavroula Kyriakaki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

16 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

number of pages

6

1 reference

inferred from page(s)

published in

Tumor Biology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

859-864

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242610%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s13277-012-0618-6

20 February 2020

exact match

0 references

cites work

Molecular pathogenesis of multiple myeloma: chromosomal aberrations, changes in gene expression, cytokine networks, and the bone marrow microenvironment

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0618-6

Biological aspects of angiogenesis in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0618-6

Monoclonal antibody Ki-67: its use in histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0618-6

Ki-67 proliferation index: correlation with prognostic parameters and outcome in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0618-6

The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0618-6

Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0618-6

Interleukin-6 in bone metastasis and cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0618-6

Evidence of IL-18 as a novel angiogenic mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0618-6

Interleukin-6 trans-signalling in chronic inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0618-6

An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0618-6

The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0618-6

Proinflammatory and antitumor properties of interleukin-18 in the gastrointestinal tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0618-6

R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0618-6

Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0618-6

Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0618-6

Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood

21 January 2018

1 reference

12 December 2020

Serum concentrations and clinical significance of soluble CD40 ligand in patients with multiple myeloma

1 reference

12 December 2020

Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity

1 reference

12 December 2020

Immunohistochemical expression of the p53, p21/Waf-1, Rb, p16 and Ki67 proteins in multiple myeloma

1 reference

12 December 2020

Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies

1 reference

12 December 2020

Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group

1 reference

12 December 2020

The biological and clinical significance of the KI-67 growth fraction in multiple myeloma

1 reference

12 December 2020

Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma

1 reference

12 December 2020

Clinical significance of IL-18 gene over-expression in AML

1 reference

12 December 2020

Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival

1 reference

12 December 2020

Basic FGF and Ki‐67 proteins useful for immunohistological diagnostic evaluations in malignant solitary fibrous tumor

1 reference

12 December 2020

1 reference

12 December 2020

Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma

1 reference

12 December 2020

IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells

1 reference

12 December 2020

Serum syndecan-1: a new independent prognostic marker in multiple myeloma

1 reference

12 December 2020

Expression of the cell-cycle-related proteins E2F-1, p53, mdm-2, p21waf-1, and Ki-67 in multiple myeloma: correlation with cyclin-D1 immunoreactivity.

1 reference

12 December 2020

IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family

1 reference

12 December 2020

The dual effects of interleukin-18 in tumor progression.

1 reference

12 December 2020

The prognostic value of soluble interleukin-6 receptor in patients with multiple myeloma

1 reference

12 December 2020

Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma

1 reference

12 December 2020

Hepatocyte growth factor and its receptor c-met in multiple myeloma

1 reference

12 December 2020

Analysis of cell cycle-related Ki-67 and p120 expression by flow cytometric BrdUrd-Hoechst/7AAD and immunolabeling technique

1 reference

12 December 2020

Antisense treatment against Ki‐67 mRNA inhibits proliferation and tumor growth in vitro and in vivo

1 reference

12 December 2020

Clinical significance of sCD105 in angiogenesis and disease activity in multiple myeloma

1 reference

12 December 2020

10.1007/S13277-012-0618-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference